Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs TransMedics Group Inc (TMDX) Price & Performance

iShares JPMorgan USD Emerging Markets Bond ETFTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

iShares JPMorgan USD Emerging Markets Bond ETF vs TransMedics Group Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $94.83, while TransMedics Group Inc trades at $89.19 (market cap $3.10B). Which is the better fit depends on your goals.

EMBTMDX
Sector
Fixed IncomeTechnology
52-Week High
$97.74$150.42
52-Week Low
$92.95$61.99
Market Cap
$3.10B
Enterprise Value
$3.49B

Returns comparison

Trailing returns across standard periods

About iShares JPMorgan USD Emerging Markets Bond ETF

EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.

Read more on EMB

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX